Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexia Iasonos

Showing results (71-80 of 270) with videos related to

Pageof 27
Sort By:
JCO Precision Oncology|September 11, 2020
Specifying the True- and False-Positive Rates in Basket TrialsKristen M Cunanan, Alexia Iasonos, Ronglai Shen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2011
Identifying clinical improvement in consolidation single-arm phase 2 trials in patients with ovarian cancer in second or greater clinical remissionAlexia Iasonos, Paul Sabbatini, David R Spriggs, et al.
Gynecologic Oncology|September 26, 2015
Ovarian clear cell carcinoma, outcomes by stage: the MSK experienceCatherine A Shu, Qin Zhou, Anjali R Jotwani, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 11, 2010
Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16Thapi Dharma Rao, Kay J Park, Peter Smith-Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Positron Lymphography via Intracervical <sup>18</sup>F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial MalignanciesJennifer J Mueller, Lawrence T Dauer, Rajmohan Murali, et al.
Gynecologic Oncology|August 30, 2008
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcomaVicky Makker, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.
Gynecologic Oncology|October 20, 2009
Consolidation strategies in ovarian cancer: observations for future clinical trialsPaul Sabbatini, David Spriggs, Carol Aghajanian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2026
Brief Report: First-line Chemoimmunotherapy and Chemotherapy Outcomes in Patients with RET Fusion-Positive Lung Cancer in LIBRETTO-431Can Cui, Sabrina Lin, Sarah Waliany, et al.
Gynecologic Oncology|July 7, 2007
Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trialsMichelle L Harrison, Martin E Gore, David Spriggs, et al.
Gynecologic Oncology|June 3, 2006
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer CenterNadeem R Abu-Rustum, Kaled Alektiar, Alexia Iasonos, et al.
Pageof 27

Showing results (71-80 of 270) with videos related to

Sort By:
Pageof 27
JCO Precision Oncology|September 11, 2020
Specifying the True- and False-Positive Rates in Basket TrialsKristen M Cunanan, Alexia Iasonos, Ronglai Shen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2011
Identifying clinical improvement in consolidation single-arm phase 2 trials in patients with ovarian cancer in second or greater clinical remissionAlexia Iasonos, Paul Sabbatini, David R Spriggs, et al.
Gynecologic Oncology|September 26, 2015
Ovarian clear cell carcinoma, outcomes by stage: the MSK experienceCatherine A Shu, Qin Zhou, Anjali R Jotwani, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 11, 2010
Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16Thapi Dharma Rao, Kay J Park, Peter Smith-Jones, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Positron Lymphography via Intracervical <sup>18</sup>F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial MalignanciesJennifer J Mueller, Lawrence T Dauer, Rajmohan Murali, et al.
Gynecologic Oncology|August 30, 2008
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcomaVicky Makker, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.
Gynecologic Oncology|October 20, 2009
Consolidation strategies in ovarian cancer: observations for future clinical trialsPaul Sabbatini, David Spriggs, Carol Aghajanian, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2026
Brief Report: First-line Chemoimmunotherapy and Chemotherapy Outcomes in Patients with RET Fusion-Positive Lung Cancer in LIBRETTO-431Can Cui, Sabrina Lin, Sarah Waliany, et al.
Gynecologic Oncology|July 7, 2007
Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trialsMichelle L Harrison, Martin E Gore, David Spriggs, et al.
Gynecologic Oncology|June 3, 2006
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer CenterNadeem R Abu-Rustum, Kaled Alektiar, Alexia Iasonos, et al.
Pageof 27